Statins modulate transcriptional activity of heme-oxygenase-1 promoter in NIH 3T3 Cells

Journal of Cellular Biochemistry

Volumn 113, Issue 11, 2012, Pages 3466-3475

  Mrad, May F ^a   Mouawad, Charbel A ^a   Al Hariri, Moustafa ^a   Eid, Assaad A ^a   Alam, Jawed ^b,c   Habib, Aïda ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b OCHSNER CLINIC FOUNDATION   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

C EBP; HEME OXYGENASE 1; siRNA; STATINS; USF

Indexed keywords

ANTIBODY; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; DNA; FLUINDOSTATIN; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LUCIFERASE; MESSENGER RNA; MYC PROTEIN; SIMVASTATIN; UPSTREAM STIMULATORY FACTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA BINDING; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; MODULATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; FATTY ACIDS, MONOUNSATURATED; GENE EXPRESSION; GENES, REPORTER; HEME OXYGENASE-1; INDOLES; LUCIFERASES; MICE; NIH 3T3 CELLS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, MESSENGER; SIGNAL TRANSDUCTION; SIMVASTATIN; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; UP-REGULATION; UPSTREAM STIMULATORY FACTORS;

EID: 84866510855     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24223     Document Type: Article

References (58)

1. Alam J,. 1994. Multiple elements within the 5' distal enhancer of the mouse heme oxygenase-1 gene mediate induction by heavy metals. J Biol Chem 269: 25049-25056.
2. Alam J, Cai J, Smith A,. 1994. Isolation and characterization of the mouse heme oxygenase-1 gene. Distal 5' sequences are required for induction by heme or heavy metals. J Biol Chem 269: 1001-1009.
3. Alam J, Cook JL,. 2007. How many transcription factors does it take to turn on the heme oxygenase-1 gene ? Am J Respir Cell Mol Biol 36: 166-174.
4. Alam J, Den Z,. 1992. Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J Biol Chem 267: 21894-21900.
5. Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, Rothrock J, Lopez M, Joshua H, Harris E, Patchett A, Monaghan R, Currie S, Stapley E, Albers-Schonberg G, Hensens O, Hirshfield J, Hoogsteen K, Liesch J, Springer J,. 1980. Mevinolin: A highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 77: 3957-3961.
6. Alcaraz MJ, Habib A, Lebret M, Creminon C, Levy-Toledano S, Maclouf J,. 2000. Enhanced expression of haem oxygenase-1 by nitric oxide and antiinflammatory drugs in NIH 3T3 fibroblasts. Br J Pharmacol 130: 57-64.
7. Ali F, Hamdulay SS, Kinderlerer AR, Boyle JJ, Lidington EA, Yamaguchi T, Soares MP, Haskard DO, Randi AM, Mason JC,. 2007. Statin-mediated cytoprotection of human vascular endothelial cells: A role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. J Thromb Haemost 5: 2537-2546.
8. Atchley WR, Fitch WM,. 1997. A natural classification of the basic helix-loop-helix class of transcription factors. Proc Natl Acad Sci USA 94: 5172-5176.
9. Baglole CJ, Sime PJ, Phipps RP,. 2008. Cigarette smoke-induced expression of heme oxygenase-1 in human lung fibroblasts is regulated by intracellular glutathione. Am J Physiol Lung Cell Mol Physiol 295: L624-L636.
10. Bartok B, Firestein GS,. 2010. Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunol Rev 233: 233-255.
11. Buhaescu I, Izzedine H,. 2007. Mevalonate pathway: A review of clinical and therapeutical implications. Clin Biochem 40: 575-584.
12. Carlin CM, Peacock AJ, Welsh DJ,. 2007. Fluvastatin inhibits hypoxic proliferation and p38 MAPK activity in pulmonary artery fibroblasts. Am J Respir Cell Mol Biol 37: 447-456.
13. Chen JC, Huang KC, Lin WW,. 2006. HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways. Cell Signal 18: 32-39.
14. Chi PL, Chen YW, Hsiao LD, Chen YL, Yang CM,. 2012. HO-1 attenuates IL-1beta-induced cPLA(2) expression via a decrease in NADPH oxidase/ROS/AP-1 activation in human rheumatoid arthritis synovial fibroblasts. Arthritis Rheum.
15. Corre S, Primot A, Baron Y, Le Seyec J, Goding C, Galibert MD,. 2009. Target gene specificity of USF-1 is directed via p38-mediated phosphorylation-dependent acetylation. J Biol Chem 284: 18851-18862.
16. Degraeve F, Bolla M, Blaie S, Creminon C, Quere I, Boquet P, Levy-Toledano S, Bertoglio J, Habib A,. 2001. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins. J Biol Chem 276: 46849-46855.
17. Dichtl W, Dulak J, Frick M, Alber HF, Schwarzacher SP, Ares MP, Nilsson J, Pachinger O, Weidinger F,. 2003. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23: 58-63.
18. Durante W,. 2012. Protective role of heme oxygenase-1 against inflammation in atherosclerosis. Front Biosci 17: 2372-2388.
19. Fisher DE, Parent LA, Sharp PA,. 1992. Myc/Max and other helix-loop-helix/leucine zipper proteins bend DNA toward the minor groove. Proc Natl Acad Sci USA 89: 11779-11783.
20. Habeos IG, Ziros PG, Chartoumpekis D, Psyrogiannis A, Kyriazopoulou V, Papavassiliou AG,. 2008. Simvastatin activates Keap1/Nrf2 signaling in rat liver. J Mol Med (Berl) 86: 1279-1285.
21. Habib A, Shamseddeen I, Nasrallah MS, Antoun TA, Nemer G, Bertoglio J, Badreddine R, Badr KF,. 2007. Modulation of COX-2 expression by statins in human monocytic cells. FASEB J 21: 1665-1674.
22. Hira S, Tomita T, Matsui T, Igarashi K, Ikeda-Saito M,. 2007. Bach1, a heme-dependent transcription factor, reveals presence of multiple heme binding sites with distinct coordination structure. IUBMB Life 59: 542-551.
23. Hock TD, Nick HS, Agarwal A,. 2004. Upstream stimulatory factors, USF1 and USF2, bind to the human haem oxygenase-1 proximal promoter in vivo and regulate its transcription. Biochem J 383: 209-218.
24. Holschermann H, Schuster D, Parviz B, Haberbosch W, Tillmanns H, Muth H,. 2006. Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells. Atherosclerosis 185: 240-245.
25. Huang W, Shang WL, Li DH, Wu WW, Hou SX,. 2012. Simvastatin protects osteoblast against H2O2-induced oxidative damage via inhibiting the upregulation of Nox4. Mol Cell Biochem 360: 71-77.
26. Igarashi K, Sun J,. 2006. The heme-Bach1 pathway in the regulation of oxidative stress response and erythroid differentiation. Antioxid Redox Signal 8: 107-118.
27. Iwata A, Shirai R, Ishii H, Kushima H, Otani S, Hashinaga K, Umeki K, Kishi K, Tokimatsu I, Hiramatsu K, Kadota J,. 2012. Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells. Clin Exp Immunol 168: 234-240.
28. Kie JH, Kapturczak MH, Traylor A, Agarwal A, Hill-Kapturczak N,. 2008. Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis. J Am Soc Nephrol 19: 1681-1691.
29. Kim JH, Yang JI, Jung MH, Hwa JS, Kang KR, Park DJ, Roh GS, Cho GJ, Choi WS, Chang SH,. 2006. Heme oxygenase-1 protects rat kidney from ureteral obstruction via an antiapoptotic pathway. J Am Soc Nephrol 17: 1373-1381.
30. Laufs U, Liao JK,. 2000. Targeting Rho in cardiovascular disease. Circ Res 87: 526-528.
31. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AM,. 1997. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272: 5375-5381.
32. Lee TS, Chang CC, Zhu Y, Shyy JY,. 2004. Simvastatin induces heme oxygenase-1: A novel mechanism of vessel protection. Circulation 110: 1296-1302.
33. Lee TS, Chau LY,. 2002. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 8: 240-246.
34. Li L, Grenard P, Nhieu JT, Julien B, Mallat A, Habib A, Lotersztajn S,. 2003. Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts. Gastroenterology 125: 460-469.
35. Liao JK,. 2005. Clinical implications for statin pleiotropy. Curr Opin Lipidol 16: 624-629.
36. Liao JK, Laufs U,. 2005. Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45: 89-118.
37. Mayer C, Gruber HJ, Landl EM, Pailer S, Scharnagl H, Truschnig-Wilders M, Marz W,. 2007. Rosuvastatin reduces interleukin-6-induced expression of C-reactive protein in human hepatocytes in a STAT3- and C/EBP-dependent fashion. Int J Clin Pharmacol Ther 45: 319-327.
38. Naito Y, Takagi T, Uchiyama K, Yoshikawa T,. 2011. Heme oxygenase-1: A novel therapeutic target for gastrointestinal diseases. J Clin Biochem Nutr 48: 126-133.
39. Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S,. 2010. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 80: 1895-1903.
40. Parmar KM, Nambudiri V, Dai G, Larman HB, Gimbrone MA Jr, Garcia-Cardena G,. 2005. Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem 280: 26714-26719.
41. Pugazhenthi S, Akhov L, Selvaraj G, Wang M, Alam J,. 2007. Regulation of heme oxygenase-1 expression by demethoxy curcuminoids through Nrf2 by a PI3-kinase/Akt-mediated pathway in mouse beta-cells. Am J Physiol Endocrinol Metab 293: E645-E655.
42. Raval CM, Zhong JL, Mitchell SA, Tyrrell RM,. 2012. The role of Bach1 in ultraviolet A-mediated human heme oxygenase 1 regulation in human skin fibroblasts. Free Radic Biol Med 52: 227-236.
43. Rikitake Y, Liao JK,. 2005. Rho GTPases, statins, and nitric oxide. Circ Res 97: 1232-1235.
44. Ryter SW, Alam J, Choi AM,. 2006. Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol Rev 86: 583-650.
45. Schaafsma D, McNeill KD, Mutawe MM, Ghavami S, Unruh H, Jacques E, Laviolette M, Chakir J, Halayko AJ,. 2011. Simvastatin inhibits TGFbeta1-induced fibronectin in human airway fibroblasts. Respir Res 12: 113.
46. Schrem H, Klempnauer J, Borlak J,. 2004. Liver-enriched transcription factors in liver function and development. Part II: The C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol Rev 56: 291-330.
47. Sebti SM,. 2005. Protein farnesylation: Implications for normal physiology, malignant transformation, and cancer therapy. Cancer Cell 7: 297-300.
48. Sen-Banerjee S, Mir S, Lin Z, Hamik A, Atkins GB, Das H, Banerjee P, Kumar A, Jain MK,. 2005. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation 112: 720-726.
49. Solini A, Rossi C, Santini E, Madec S, Salvati A, Ferrannini E,. 2011. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation. J Hypertens 29: 1930-1939.
50. Sundararaj KP, Samuvel DJ, Li Y, Nareika A, Slate EH, Sanders JJ, Lopes-Virella MF, Huang Y,. 2008. Simvastatin suppresses LPS-induced MMP-1 expression in U937 mononuclear cells by inhibiting protein isoprenylation- mediated ERK activation. J Leukoc Biol 84: 1120-1129.
51. Szentirmay MN, Yang HX, Pawar SA, Vinson C, Sawadogo M,. 2003. The IGF2 receptor is a USF2-specific target in nontumorigenic mammary epithelial cells but not in breast cancer cells. J Biol Chem 278: 37231-37240.
52. Tsukada J, Yoshida Y, Kominato Y, Auron PE,. 2011. The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation. Cytokine 54: 6-19.
53. Tuomisto TT, Lumivuori H, Kansanen E, Hakkinen SK, Turunen MP, van Thienen JV, Horrevoets AJ, Levonen AL, Yla-Herttuala S,. 2008. Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2. Cardiovasc Res 78: 175-184.
54. Tyrrell RM,. 2004. Solar ultraviolet A radiation: An oxidizing skin carcinogen that activates heme oxygenase-1. Antioxid Redox Signal 6: 835-840.
55. Vicente AM, Guillen MI, Habib A, Alcaraz MJ,. 2003. Beneficial effects of heme oxygenase-1 up-regulation in the development of experimental inflammation induced by zymosan. J Pharmacol Exp Ther 307: 1030-1037.
56. Wada H, Abe M, Ono K, Morimoto T, Kawamura T, Takaya T, Satoh N, Fujita M, Kita T, Shimatsu A, Hasegawa K,. 2008. Statins activate GATA-6 and induce differentiated vascular smooth muscle cells. Biochem Biophys Res Commun 374: 731-736.
57. Zhang X, Bedard EL, Potter R, Zhong R, Alam J, Choi AM, Lee PJ,. 2002. Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemia-reperfusion lung injury. Am J Physiol Lung Cell Mol Physiol 283: L815-L829.
58. Zhou Q, Gensch C, Liao JK,. 2011. Rho-associated coiled-coil-forming kinases (ROCKs): Potential targets for the treatment of atherosclerosis and vascular disease. Trends Pharmacol Sci 32: 167-173.